Trials / Sponsors / Apexigen America, Inc.
Apexigen America, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Study to Evaluate Sotigalimab (APX005M) in Subjects With Unresectable or Metastatic Melanoma Unresectable Melanoma, Metastatic Melanoma, Cancer | Phase 2 | 2019-06-12 |
| Completed | APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers Esophageal Cancer, GastroEsophageal Cancer | Phase 2 | 2017-10-06 |
| Completed | CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab Cancer, Non Small Cell Lung Cancer Metastatic, Metastatic Melanoma | Phase 1 / Phase 2 | 2017-07-10 |
| Completed | Study of the CD40 Agonistic Monoclonal Antibody APX005M Cancer, NSCLC, Melanoma | Phase 1 | 2015-05-01 |